Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus

Conditions: Systemic Lupus Erythematosus Interventions: Biological: Blood sample; Drug: Treatment :Abacavir 600 mg/lamivudine 300 mg; Other: Lupus Impact Tracker questionnaire Sponsors: Hospices Civils de Lyon Not yet recruiting

https://clinicaltrials.gov/study/NCT06356740

Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

More News: Lupus | Research